Canada · Delayed Price · Currency is CAD Green Thumb Industries Earnings Call Transcripts
Fiscal Year 2025
-
Q2 2025 revenue rose 5% to $293M, with adjusted EBITDA of $83M and strong CPG growth, but price compression and regulatory uncertainty pressured margins. The company is investing in THC beverages, expanding market share, and maintaining a strong balance sheet.
-
The meeting covered director elections, executive compensation, auditor appointment, and an amendment to the share plan, with all motions passing by majority vote. No shareholder questions were submitted during the session.
-
Revenue grew 1% year-over-year to $280M, with adjusted EBITDA at $85M and strong cash flow, despite pricing pressures and increased competition. The company maintains a robust balance sheet, focuses on operational efficiency, and expects flat revenue and margin compression in the next quarter.
Fiscal Year 2024
-
Record Q4 revenue and EBITDA were achieved despite ongoing pricing pressure and regulatory uncertainty. Strong cash flow and balance sheet enabled continued investment in growth, innovation, and market expansion, positioning the company to capitalize on rising THC demand and industry shifts.
-
Q3 2024 revenue grew 4% year-over-year to $287 million, with strong CPG and wholesale gains offsetting flat retail sales and ongoing price compression. Strategic debt refinancing improved the balance sheet, while new store openings and brand partnerships expanded market reach.
-
Q2 2024 saw 11% revenue growth to $280M, record cash flow, and margin expansion despite price pressure. Share buybacks, CapEx investments, and new market launches, including Ohio adult-use, position the company for continued growth amid regulatory and economic uncertainty.